NCT00283465View on ClinicalTrials.gov

A Study of the Effectiveness and Safety of Treatment With Epoetin Alfa on Hemoglobin Levels, Red Blood Cell Transfusions, and Quality of Life in Patients With Cancer Receiving Platinum-containing Chemotherapy

PHASE4CompletedINTERVENTIONAL
Enrollment

316

Participants

Timeline

Start Date

November 30, 1999

Study Completion Date

April 30, 2004

Conditions
AnemiaNeoplasm
Interventions
DRUG

Epoetin alfa

All Listed Sponsors
lead

Janssen-Cilag B.V.

INDUSTRY

NCT00283465 - A Study of the Effectiveness and Safety of Treatment With Epoetin Alfa on Hemoglobin Levels, Red Blood Cell Transfusions, and Quality of Life in Patients With Cancer Receiving Platinum-containing Chemotherapy | Biotech Hunter | Biotech Hunter